ClariTrial — AI Clinical Trial Intelligence

Explore/Alzheimer Disease

Status

Phase

5,383 results for “Alzheimer Disease”

Page 1 of 359

NCT03484143

Suspended

Neuro RX Gamma - Pivotal Phase

N/AAlzheimer Disease

Active Neuro RX Gamma deviceSham Neuro RX Gamma device

Vielight Inc.228 participants9 sites · United States, CanadaCompletes May 2023

CT.gov Full analysis →

NCT02509117

Completed

Results posted

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

Phase 1Healthy Subjects

PF-06751979 single ascending dosePlacebo single dosePF-06751979 multiple ascending dose+3 more

Pfizer55 participants2 sites · United StatesCompletes Jul 2016

CT.gov Full analysis →

NCT05349318

UNKNOWN

Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease

N/AProdromal Alzheimer's DiseaseCerebral Vascular DisorderMild Cognitive Impairment

Hyperbaric oxygen therapySham

Assaf-Harofeh Medical Center100 participants1 site · IsraelCompletes Aug 2024

CT.gov Full analysis →

NCT03923920

Completed

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

N/AAmyloidAmyloidosisSpinal Stenosis

Biopsy

The Cleveland Clinic200 participants1 site · United StatesCompletes Oct 2021

CT.gov Full analysis →

NCT07414680

Not Yet Recruiting

Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4

N/ASleep DisturbanceCognitive ChangeAging

Chang Gung Memorial Hospital250 participants2 sites · TaiwanCompletes Dec 2028

CT.gov Full analysis →

NCT05081596

Recruiting

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

N/ADepressionPainCognitive Impairment

PATH-Pain

Weill Medical College of Cornell University100 participants1 site · United StatesCompletes Jul 2026

CT.gov Full analysis →

NCT04436341

Completed

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

N/AAlzheimer DiseaseLewy Body DiseaseEpilepsy

Danish Dementia Research Centre50 participants2 sites · DenmarkCompletes Sep 2022

CT.gov Full analysis →

NCT06411561

Recruiting

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

N/ACritical IllnessDeliriumCognitive Impairment

SLEEP + COGCOGSLEEP+1 more

University of Washington100 participants1 site · United StatesCompletes May 2027

CT.gov Full analysis →

NCT06268886

Active

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease

Phase 2Alzheimer Disease, Early Onset

BMS-986446Placebo

Bristol-Myers Squibb310 participants176 sites · United States, Australia, BelgiumCompletes Mar 2027

CT.gov Full analysis →

NCT06335173

Active

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Phase 2Alzheimer Disease

sabirnetugPlacebo

Acumen Pharmaceuticals542 participants68 sites · United States, Canada, GermanyCompletes Oct 2026

CT.gov Full analysis →

NCT05866094

Completed

nuTritiOn and deMentia AT hOme (TOMATO)

N/ADementiaUndernutrition

Nutritional Intervention

Bournemouth University139 participants5 sites · United KingdomCompletes Dec 2024

CT.gov Full analysis →

NCT04619420

Active

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Phase 2Alzheimer DiseaseCognitive DysfunctionDementia

JNJ-63733657Placebo

Janssen Research & Development, LLC523 participants122 sites · United States, Australia, BelgiumCompletes Oct 2025

CT.gov Full analysis →

NCT04705220

Completed

Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome

N/AMild Cognitive Impairment

MERIVA® TabletsPlacebo Tablets

Indena S.p.A85 participants1 site · ItalyCompletes Oct 2025

CT.gov Full analysis →

NCT03863041

Completed

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

N/AMemory ComplaintAlzheimer DiseasePhosphorylated Metabolism Profile

Additional sequence performed during MRI scan

Poitiers University Hospital49 participants1 site · FranceCompletes Jun 2023

CT.gov Full analysis →

NCT00001480

Completed

The Evaluation and Follow-up of Individuals With Memory Disorder

N/AAlzheimer's DiseaseDementiaHealthy

National Institute of Mental Health (NIMH)750 participants2 sites · United States

CT.gov Full analysis →

1–15 of 5,383

Explore/Alzheimer Disease

Status

Phase

5,383 results for “Alzheimer Disease”

Page 1 of 359

NCT03484143

Suspended

Neuro RX Gamma - Pivotal Phase

N/AAlzheimer Disease

Active Neuro RX Gamma deviceSham Neuro RX Gamma device

Vielight Inc.228 participants9 sites · United States, CanadaCompletes May 2023

CT.gov Full analysis →

NCT02509117

Completed

Results posted

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

Phase 1Healthy Subjects

PF-06751979 single ascending dosePlacebo single dosePF-06751979 multiple ascending dose+3 more

Pfizer55 participants2 sites · United StatesCompletes Jul 2016

CT.gov Full analysis →

NCT05349318

UNKNOWN

Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease

N/AProdromal Alzheimer's DiseaseCerebral Vascular DisorderMild Cognitive Impairment

Hyperbaric oxygen therapySham

Assaf-Harofeh Medical Center100 participants1 site · IsraelCompletes Aug 2024

CT.gov Full analysis →

NCT03923920

Completed

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

N/AAmyloidAmyloidosisSpinal Stenosis

Biopsy

The Cleveland Clinic200 participants1 site · United StatesCompletes Oct 2021

CT.gov Full analysis →

NCT07414680

Not Yet Recruiting

Integrating Systematic Data of Medicine to Explore the Solution for Healthy Aging (ISDHA) Phase 4

N/ASleep DisturbanceCognitive ChangeAging

Chang Gung Memorial Hospital250 participants2 sites · TaiwanCompletes Dec 2028

CT.gov Full analysis →

NCT05081596

Recruiting

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

N/ADepressionPainCognitive Impairment

PATH-Pain

Weill Medical College of Cornell University100 participants1 site · United StatesCompletes Jul 2026

CT.gov Full analysis →

NCT04436341

Completed

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

N/AAlzheimer DiseaseLewy Body DiseaseEpilepsy

Danish Dementia Research Centre50 participants2 sites · DenmarkCompletes Sep 2022

CT.gov Full analysis →

NCT06411561

Recruiting

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

N/ACritical IllnessDeliriumCognitive Impairment

SLEEP + COGCOGSLEEP+1 more

University of Washington100 participants1 site · United StatesCompletes May 2027

CT.gov Full analysis →

NCT06268886

Active

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease

Phase 2Alzheimer Disease, Early Onset

BMS-986446Placebo

Bristol-Myers Squibb310 participants176 sites · United States, Australia, BelgiumCompletes Mar 2027

CT.gov Full analysis →

NCT06335173

Active

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Phase 2Alzheimer Disease

sabirnetugPlacebo

Acumen Pharmaceuticals542 participants68 sites · United States, Canada, GermanyCompletes Oct 2026

CT.gov Full analysis →

NCT05866094

Completed

nuTritiOn and deMentia AT hOme (TOMATO)

N/ADementiaUndernutrition

Nutritional Intervention

Bournemouth University139 participants5 sites · United KingdomCompletes Dec 2024

CT.gov Full analysis →

NCT04619420

Active

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Phase 2Alzheimer DiseaseCognitive DysfunctionDementia

JNJ-63733657Placebo

Janssen Research & Development, LLC523 participants122 sites · United States, Australia, BelgiumCompletes Oct 2025

CT.gov Full analysis →

NCT04705220

Completed

Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome

N/AMild Cognitive Impairment

MERIVA® TabletsPlacebo Tablets

Indena S.p.A85 participants1 site · ItalyCompletes Oct 2025

CT.gov Full analysis →

NCT03863041

Completed

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

N/AMemory ComplaintAlzheimer DiseasePhosphorylated Metabolism Profile

Additional sequence performed during MRI scan

Poitiers University Hospital49 participants1 site · FranceCompletes Jun 2023

CT.gov Full analysis →

NCT00001480

Completed

The Evaluation and Follow-up of Individuals With Memory Disorder

N/AAlzheimer's DiseaseDementiaHealthy

National Institute of Mental Health (NIMH)750 participants2 sites · United States

CT.gov Full analysis →

1–15 of 5,383